To validate whether PP4 silencing could ameliorate TNF-α-induced hepatic insulin resistance in vivo, we injected AD-PP4 shRNA into the tail veils of C57BL/6J mice treated with or without TNF-α. The gene discussed is TNF; the disease is Insulin resistance.